Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques
NCT ID: NCT02208414
Last Updated: 2014-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2012-06-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: experimental group will show a significant improvement over the control group in allergic symptom, serum crab- or shrimp-specific IgE and skin test for crab or shrimp extract.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Importance of Hand Washing After Each NAET® Treatment
NCT00292656
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
NCT01489514
Skin Prick Test for the Diagnosis of Food Allergy- a Comparison of Different Commercial Extracts and Raw Food
NCT01508299
Efficacy of Lyophilized Food Extracts for Skin Prick Tests and Atopy Patch Test at Different Storage Time
NCT03645629
Etanercept for the Treatment of Chronic Urticaria
NCT01030120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Lack of well-controlled clinical study prevents NAET from being accepted as a treatment option in current medical system.
The aim of this project is to conduct a double blind-placebo controlled study of applying NAET to treat crab or shrimp allergy.
The parameters to be measured are allergic symptom, crab- or shrimp-specific IgE and skin test before and after NAET treatment
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crab or shrimp
Intervention: treated with crab and shrimp energy signature vial using NAET
NAET
NAET with acupressure and/or chiropractic procedures with the participant holding crab and shrimp energy signature vial
Placebo
Treated with water vial
NAET
NAET with acupressure and/or chiropractic procedures with the participant holding water vial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NAET
NAET with acupressure and/or chiropractic procedures with the participant holding crab and shrimp energy signature vial
NAET
NAET with acupressure and/or chiropractic procedures with the participant holding water vial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of allergic to crab or shrimp
* Positive serum crab- or shrimp-specific IgE
Exclusion Criteria
* On medication of anti-histamine or steroid
* Pregnancy
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cha Ze Lee, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201111069RID
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.